HansenBC. The metabolic syndrome X. Ann NY Acad Sci892: 124, 1999.
2.
ReavenGM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes37: 15951607, 1988.
3.
OrtmeyerHK, BodkinNL, HansenBC. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol265: R552R558, 1993.
4.
PravenecM, ZidekV, SimakovaM, KrenV, KrenovaD, HorkyK, JachymovaM, MikovaB, KazdovaL, AitmanTJ, ChurchillPC, WebbRC, HingarhNH, YangY, WangJM, LezinEM, KurtzTW. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest103: 16511657, 1999.
5.
DuClosTW. Function of C-reactive protein. Ann Med32: 274278, 2000.
6.
KoenigW, SundM, FrohlichM, FischerHG, LowelH, DoringA, HutchinsonWL, PepysMB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease): Augsburg cohort study, 1984 to 1992. Circulation99: 237242, 1999.
7.
MendellMA, PatelP, BallamL, StrachanD, NorthfieldTC. C reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. Br Med J312: 10611065, 1996.
8.
VisserM, BouterLM, McQuillanGM, WenerMH, HarrisTB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc282: 21312135, 1999.
CrichtonMB, NicholsJE, ZhaoY, BulunSE, SimpsonER. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol118: 215220, 1996.
11.
Mohamed-AliV, GoodrickS, RaweshA, KatzDR, MilesJM, YudkinJS, KleinS, LoppackSW. Subcutaneous adipose tissue release interleukin-6, but not tumor necrosis factor-3, in vivo. J Clin Endocrinol Metab82: 41964200, 1997.
12.
FriedSK, BunkinDA, GreenbergAS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab83: 847850, 1998.
13.
BastardJP, JardelC, DelattreJ, HainqueB, BruckertE, OberlinF. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation99: 22212222, 1999.
14.
SzalaiAJ, van GinkelFW, DalrympleSA, MurrayR, McGheeJR, VolanakisJE. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol160: 52945299, 1998.
15.
TsukuiS, KandaT, NaraM, NishinoM, KondoT, KobayashiI. Moderate-intensity regular exercise decreases tumor necrosis factor-α and HbA1c levels, in healthy women. Int J Obesity24: 12071211, 2000.
16.
Zahorska-MarkiewiczB, JanowskaJ, Olszanecka-GlinianowiczM, ZurakowskiA. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obesity24: 13921395, 2000.
17.
ChuN-F, SpiegelmanD, RifaiN, HotamisligilGS, RimmEB. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obesity24: 10851092, 2000.
LuheshiGN, GardnerJD, RushforthDA, LoudonAS, RothwellNJ. Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A96: 70477052, 1999.
20.
DasUN. Is obesity an inflammatory condition?Nutrition17: 953966, 2001.
XuZ, TongC, EisenachJC. Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology85: 107111, 1996.
23.
ChoL, TsunodaM, SharmaRP. Effects of endotoxin and tumor necrosis factor-α on regional brain neurotransmitters in mice. Nat Toxins7: 187195, 1999.
24.
VentersHD, DantzerR, KelleyKW. A new concept in neurodegeneration: TNF-α is a silencer of survival signals. Trends Neurosci23: 175180, 2000.
25.
LiangY, LuoS, CincottaAH. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet cell function. Metabolism48: 12871289, 1999.
26.
ErikssonJG, ForsenT, TuomilehtoJ, WinterPD, OsmondC, BarkerDJP. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. Br Med J318: 427431, 1999.
27.
von KriesR, KolletzkoB, SauerwaldT, von MutiusE. Does breastfeeding protect against childhood obesity?Adv Exp Med Biol478: 2939, 2000.
28.
FrohlichM, ImhofA, BergG, HutchinsonWL, PepysMB, BoeingH, MucheR, BrennerH, KoenigW. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care23: 18351839, 2000.
29.
FestaA, D'agostinoRJr, HowardG, MykkanenL, TracyRP, HaffnerSM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation102: 4247, 2000.
30.
RossR. Atherosclerosis-an inflammatory disease. N Engl J Med340: 115126, 1999.
31.
HuberSA, SakkinenP, ConzaD, HardinN, TracyR. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol19: 23642367, 1999.
32.
BraunwaldE. Shattuck Lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med337: 13601369, 1997.
33.
RidkerPM, BuringJE, ShihH, MatiasM, HennekensCH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation98: 731733, 1998.
34.
RidkerPM, HennekensCH, BuringJE, RifaiN. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med342: 836843, 2000.
35.
LindahlB, TossH, SiegbahnA, VengeP, WallentinL. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med343: 11391147, 2000.
36.
PirroM, BergeronJ, DagenaisGR, BernardPM, CantinB, DespresJP, LamarcheB. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Int Med161: 24742480, 2001.
37.
LindmarkE, DiderholmE, WallentinL, SiegbahnA. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease. J Am Med Assoc286: 21072113, 2001.
38.
ZhangR, BrennanM-L, FuX, AvilesRJ, PearceGL, PennMS, TopolEJ, SprecherDL, HazenSL. Association between myeloperoxidase levels and risk of coronary artery disease. J Am Med Assoc286: 21362142, 2001.
39.
RidkerPM, CushmanM, StampferMJ, TracyRP, HennekensCH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med336: 973979, 1997.
40.
VaneJR. The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs33(Suppl 1):1827, 1987.
41.
KannelWB, WolfPA, GarrisonRJ. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Bethesda, MD: National Heart, Lung, and Blood Institute, 1987. (NIH publication no. 87–2703).
42.
WebberLS, VoorsAW, SrinivasanSR, FrerichsRR, BerensonGS. Occurrence in children of multiple risk factors for coronary artery disease: the Bogalusa Heart Study. Prev Med8: 40748, 1979.
43.
KhouryP, MorrisonJA, KellyK, MelliesM, HorvitzR, GlueckCJ. Clustering and interrelationships of coronary heart disease risk factors in school children, ages 6-19. Am J Epidemiol112: 524538, 1980.
44.
SmoakCG, BurkeGL, WebberLS, HarshaDW, SrinivasanSR, BerensonGS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults: the Bogalusa Heart Study. Am J Epidemiol125: 364372, 1987.
45.
BaoW, SrinivasanSR, WattigneyWA, BerensonGS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: the Bogalusa Heart Study. Arch Int Med154: 18421847, 1994.
46.
BerensonGS, SrinivasanSR, BaoW, NewmanWPIII, TracyRE, WattigneyWA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med338: 16501656, 1998.
47.
WhincupPH, GilgJA, PapacostaO, SeymourC, MillerGJ, AlbertiKGMM, CookDG. Early evidence of ethnic difference in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ324: 16, 2002.
48.
NapoliC, D'armientoFP, ManciniFP, PostiglioneA, WitztumJL, PalumboG, PalinskiW. Fatty streak formation occurs in human fetal aortas and is greatly influenced by maternal hypercholesterolemia. J Clin Invest100: 26802690, 1997.
49.
NaopliC, GlassCK, WiztumJL, DeutschR, D'armientoFP, PalinskiW. Influence of maternal hypecholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet354: 12341241, 1999.
50.
NapoliC, PalinskiW. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathologic implications. Eur Heart J22: 49, 2001.
51.
VozarovaB, WeyerC, HansonK, TataranniPA, BogardusC, PratleyRE. Circulating interleukin-6 in relation to adiposity, insulin action, and secretion. Obes Res9: 414417, 2001.
52.
ChambersJC, EdaS, BassettP, KarimY, ThompsonSG, GallimoreJR, PepysMB, KoonerJS. C-reactive protein, insulin resistance, central obesity, and coronary disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation104: 145150, 2001.
53.
PradhanAD, MansonJE, RifaiN, BuringJE, RidkerPM. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc286: 327334, 2001.
54.
BarzilayJI, AbrahamL, HeckbertSR, CushmanM, KullerLH, ResnickHE, TracyRP. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes50: 23842389, 2001.
55.
KirwanJP, KrishnanRK, WeaverJA, Del AguilaLF, EvansWJ. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol281: E1137E1143, 2001.
56.
LinY, RajalaMW, BergerJP, MollerDE, BarzilaiN, SchererPE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem276: 4207742083, 2001.
57.
HotamisligilGS. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med245: 621625, 1999.
58.
Fernandez-RealJM, VayredaM, RichartC, GutierrezC, BrochM, VendrellJ, RicartW. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab86: 11541159, 2001.
59.
DovioA, AngeliA. Cytokines and type 2 diabetes mellitus. J Am Med Assoc286:2233, 2001.
60.
ChaeCU, LeeRT, RifaiN, RidkerPM. Blood pressure and inflammation in apparently healthy men. Hypertension38: 399403, 2001.
61.
RostNS, WolfPA, KaseCS, Kelly-HayesM, SilbershatzH, MassaroJM, D'agostinoRB, FranzblauC, WilsonPW. Plasma concentrations of C-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke32: 25752579, 2001.
62.
TaubesG. Does inflammation cut to the heart of the matter?Science296: 242245, 2002.
63.
BarkerDJ, HalesCN, FallCH, OsmondC, PhippsK, ClarkPM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyper-lipidemia (syndrome X): relation to reduced fetal growth. Diabetologia36: 6267, 1993.
64.
LucasA, FewtrellMS, ColeTJ. Fetal origins of adult disease-the hypothesis revisited. Br Med J319: 245249, 1999.
65.
WhincupPH, CookDG, AdsheadFA, TaylorS, WalkerM, PapacostaO, AlbertiKG. Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11 year-old children. Diabetologia40: 319326, 1997.
66.
BodkinNL, OrtmeyerHK, HansenBC. Long-term dietary restriction in older-aged rhesus monkeys: effects on insulin resistance. J Gerotol Biol Sci50: B142B147, 1995.
67.
TuomilehtoJ, LindstromJ, ErikssonJG, ValleTT, HamalainenH, Ilanne-ParikkaP, Keinanen-KiukaanniemiS, LaaksoM, LouherantaA. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med344: 13431350, 2001.
68.
HuFB, MansonJE, StampferMJ, ColditzG, LiuS, SolomonCG, WillettWC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med345: 790797, 2001.
69.
SmithJK, DykesR, DouglasJE, KrishnaswamyG, BerkS. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of ischemic heart disease. J Am Med Assoc281: 17221727, 1999.
DasUN. Free radicals, cytokines, and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem215: 145152, 2000.
72.
ClappJF, KiessW. Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor-α and leptin. Am J Obstet Gynecol182: 300306, 2000.
73.
BastardJP, JardelC, BruckertE, BlondyP, CapeauJ, LavilleM, VidalH, HaniqueB. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab85: 33383342, 2000.
HoffmannJ, HaendelerJ, ZeiherAM, DimmelerS. TNFα and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem276: 4138341387, 2001.
76.
MeilhacO, RamachandranS, ChiangK, SantanamN, ParthasarathyS. Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Arterioscler Thromb Vasc Biol21: 16811688, 2001.
77.
PerreaultM, MaretteA. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med7: 11381143, 2001.
78.
DasUN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essen Fatty Acids.
79.
FallCHD, BarkerDJP, OsmondC, WinterPD, ClarkPMS, HalesCN. Relation of infant feeding to adult serum cholesterol concentration and death from ischemic heart disease. Br Med J304: 801805, 1992.
80.
McKeiguePM, MillerGJ, MarmotMG. Coronary heart disease in South Asians overseas-a review. J Clin Epidemiol42: 597609, 1989.
81.
McKeiguePM, ShahB, MarmotMG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk of South Asians. Lancet337: 382386, 1991.
82.
DasUN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition17: 337346, 2001.
83.
HuangY-J, FangVS, ChouY-C, KwokC-F, HoL-T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism46: 12521258, 1997.
84.
MoriY, MurakawaY, KatohS, HataS, YokoyamaJ, TajimaN, IkedaY, NobukataH, IshikawaT, ShibutaniY. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism46: 14581464, 1997.
85.
NobukataH, IshikawaT, ObataM, ShibutaniY. Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism49: 912919, 2000.
BorkmanM, StorlienLH, PanDA, JenkinsAB, ChisholmDJ, CambellLV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med328: 238244, 1993.
88.
CliftonPM, NestelPJ. Relationship between plasma insulin and erythrocyte fatty acid composition. Prostaglandins Leukot Essen Fatty Acids59: 191194, 1998.
89.
BarkerDJP. Fetal and Infant Origins of Adult Disease. London: BMJ Publishing, 1992.
90.
OzanneSE, MartenszND, PetryCJ, HalesCN. Maternal low protein diet in rats programs fatty acid desaturase activities in the offspring. Diabetologia41: 13371342, 1998.
91.
MercuriO, de TomasE, IiarteH. Prenatal protein depletion and δ9, δ6, and 85 desaturases in the rat. Lipids14: 822825, 1979.
92.
DhalgrenJ, NilssonC, JennischeE, HoH-P, ErikssonE, NiklassonA, BjorntorpP, WiklandKA, HolmangA. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol281: E326E334, 2001.
93.
ReselandJE, HaugenF, HollungK. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res42: 743750, 2001.
94.
BergerA, CrozierG, BisognoT, CavaliereP, InnisS, Di MarzoV. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A98: 64026406, 2001.
95.
Di MarzoV, GoparajuSK, WangL, LiuJ, BatkaiS, JaraiZ, FezzaF, MiuraGI, PalmiterRD, SugiuraT, KanosG. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature410: 822825, 2001.
96.
MaedaN, TakahashiM, FunahashiT, KiharaS, NishizawaH, KishidaK, NagaretaniH, MatsudaM, KomuroR, OuchiN, KuriyamaH, HottaK, NakamuraT, ShimomuraI, MatsuzawaY. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adiposederived protein. Diabetes50: 20942099, 2001.
97.
FebbraioM, HajjarDP, SilversteinRL. CD36: a class of scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest108: 785791, 2001.
98.
MasuzakiH, PatersonJ, ShinyamaH, MortonNM, MullinsJJ, SecklJR, FlierJS. A transgenic model of visceral obesity and the metabolic syndrome. Science294: 21662170, 2001.
99.
GumPA, ThamilarasanM, WatanabeJ, BlackstoneEH, LauerMS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease. J Am Med Assoc286: 11871194, 2001.
